Target type: biologicalprocess
Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. [GO_REF:0000022, GOC:add]
The immune system is a complex network of cells, tissues, and organs that work together to protect the body from disease. It does this by recognizing and destroying foreign substances, such as bacteria, viruses, and parasites. The immune system is constantly on the lookout for invaders, and it has a variety of mechanisms to deal with them.
One of the most important parts of the immune system is the lymphatic system. This system is made up of a network of vessels, nodes, and tissues that circulate lymph fluid throughout the body. Lymph fluid is a clear fluid that contains white blood cells, which are the soldiers of the immune system.
The immune system has two main branches: the innate immune system and the adaptive immune system. The innate immune system is the body's first line of defense against infection. It is made up of cells and mechanisms that are always present and ready to fight off invaders. These include physical barriers like skin and mucous membranes, as well as cells like macrophages and neutrophils that can engulf and destroy pathogens.
The adaptive immune system is more specialized and takes longer to develop. It is responsible for recognizing and destroying specific invaders. This system relies on cells called lymphocytes, which are specialized white blood cells that can recognize and target specific antigens. Antigens are molecules on the surface of pathogens that the immune system can recognize.
When the adaptive immune system encounters a pathogen for the first time, it takes several days to mount an effective immune response. This is because the body needs to produce specific antibodies and T cells that can recognize and target the pathogen. Once the adaptive immune system has learned to recognize a pathogen, it can mount a rapid and effective response the next time it encounters it. This is why we are immune to many diseases we have been exposed to in the past.
The immune system is a remarkable system that protects us from a wide range of diseases. However, it can also be the source of problems. For example, autoimmune diseases occur when the immune system attacks the body's own tissues. Allergies are also caused by an overactive immune response to harmless substances.
Here is a more detailed description of the biological processes involved in the immune system:
**Innate Immunity**
* Physical barriers: Skin, mucous membranes, cilia, stomach acid
* Cellular components:
* Phagocytes: Macrophages, neutrophils, dendritic cells - engulf and destroy pathogens
* Natural killer (NK) cells: Destroy infected or cancerous cells
* Complement system: A group of proteins that help to kill pathogens and promote inflammation
* Inflammatory response: A localized response to infection characterized by redness, swelling, heat, and pain. This response helps to recruit immune cells to the site of infection and to clear away pathogens.
**Adaptive Immunity**
* Cellular components:
* T lymphocytes (T cells):
* Helper T cells: Activate other immune cells
* Cytotoxic T cells: Kill infected or cancerous cells
* B lymphocytes (B cells): Produce antibodies
* Antibodies: Proteins that bind to specific antigens on pathogens and help to neutralize them.
* Memory response: The adaptive immune system remembers pathogens it has encountered before. This allows it to mount a faster and more effective response the next time it encounters the same pathogen.
**Immune system regulation**
* The immune system is carefully regulated to prevent it from attacking the body's own tissues. This regulation is achieved through a variety of mechanisms, including:
* Tolerance: The immune system learns to recognize and tolerate the body's own antigens.
* Immune checkpoints: These are mechanisms that help to control the activation and proliferation of immune cells.
* Cytokines: These are signaling molecules that help to regulate the immune response.
**Immune system disorders**
* Autoimmune diseases: The immune system attacks the body's own tissues. Examples include rheumatoid arthritis, lupus, and type 1 diabetes.
* Immunodeficiency disorders: The immune system is weakened, making the body more susceptible to infection. Examples include HIV/AIDS and severe combined immunodeficiency (SCID).
* Allergies: The immune system overreacts to harmless substances, such as pollen, dust mites, and food.
* Cancer: The immune system can sometimes fail to recognize and destroy cancerous cells.
**Conclusion**
The immune system is a vital component of human health. It protects us from a wide range of diseases and helps to maintain our overall well-being. Understanding how the immune system works is essential for developing new treatments for infectious diseases, autoimmune disorders, and cancer.
'"
Protein | Definition | Taxonomy |
---|---|---|
Interferon regulatory factor 3 | An interferon regulatory factor 3 that is encoded in the genome of human. [PRO:CNA] | Homo sapiens (human) |
Acidic mammalian chitinase | An acidic mammalian chitinase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9BZP6] | Homo sapiens (human) |
5'-3' exonuclease PLD3 | A 5-3 exonuclease PLD3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8IV08] | Homo sapiens (human) |
Indoleamine 2,3-dioxygenase 2 | An indoleamine 2,3-dioxygenase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q6ZQW0] | Homo sapiens (human) |
Adenylosuccinate synthetase isozyme 2 | An adenylosuccinate synthetase isozyme 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P30520] | Homo sapiens (human) |
Proteasome subunit beta type-9 | A proteasome subunit beta type-9 that is encoded in the genome of human. [PRO:DNx] | Homo sapiens (human) |
Proteasome subunit alpha type-1 | A proteasome subunit alpha type-1 that is encoded in the genome of human. [PRO:DNx] | Homo sapiens (human) |
Intermediate conductance calcium-activated potassium channel protein 4 | An intermediate conductance calcium-activated potassium channel protein 4 that is encoded in the genome of human. [] | Homo sapiens (human) |
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | A phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15357] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
acetazolamide | Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
chlorpromazine | chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
clotrimazole | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic | |
kinetin | cytokinin : A phytohormone that promote cell division, or cytokinesis, in plant roots and shoots. kinetin : A member of the class of 6-aminopurines that is adenine carrying a (furan-2-ylmethyl) substituent at the exocyclic amino group. Kinetin: A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects. | 6-aminopurines; furans | cytokinin; geroprotector |
8-chlorotheophylline | organochlorine compound; purines | central nervous system stimulant | |
hadacidin | hadacidin : A monocarboxylic acid that is N-hydroxyglycine in which the hydrogen attached to the nitrogen is replaced by a formyl group. It was originally isolated from cultures of Penicillium frequentans. hadacidin: inhibitor of AMP synthesis; RN given refers to parent cpd; structure | aldehyde; monocarboxylic acid; N-hydroxy-alpha-amino-acid | antimicrobial agent; antineoplastic agent; Penicillium metabolite; teratogenic agent |
triphenylacetic acid | |||
tryptanthrine | tryptanthrine: minor constituent of traditional Chinese medicine qing dai | alkaloid antibiotic; organic heterotetracyclic compound; organonitrogen heterocyclic compound | |
2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one | 2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one : A pentahydroxyflavone that is flavone substituted by hydroxy groups at positions 5, 6, 7, 8, and 4' respectively. | pentahydroxyflavone | |
inositol-1,3,4,5-tetrakisphosphate | 1D-myo-inositol 1,3,4,5-tetrakisphosphate : A myo-inositol tetrakisphosphate having the four phosphates placed in the 1-, 3-, 4- and 5-positions. inositol-1,3,4,5-tetrakisphosphate: for cpd without numerical locants of phosphate groups, index INOSITOL PHOSPHATES | inositol phosphate | |
allosamidin | allosamidin: Anti-Asthmatic | ||
thymidine 5'-4-nitrophenyl phosphate | p-nitrophenyl thymidine 5'-monophosphate : A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate that is the mono-p-nitrophenyl ester of thymidine 5'-monophosphate. thymidine 5'-4-nitrophenyl phosphate: RN given refers to parent cpd | aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | |
senicapoc | senicapoc: a Gardos channel blocker; structure in first source | ||
nsc-89199 | estramustine phosphate : A steroid phosphate which is the 17-O-phospho derivative of estramustine. | carbamate ester; organochlorine compound; steroid phosphate | |
bortezomib | amino acid amide; L-phenylalanine derivative; pyrazines | antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor | |
indoximod | |||
sdz 283-910 | SDZ 283-910: structure in first source | ||
argifin | argifin: possible lead insecticide; isolated from Gliocladium; structure in first source | ||
benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde: proteasome inhibitor N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal : A tripeptide that is L-leucyl-L-leucyl-L-leucine in which the C-terminal carboxy group has been reduced to the corresponding aldehyde and the N-terminal amino group is protected as its benzyloxycarbonyl derivative. | amino aldehyde; carbamate ester; tripeptide | proteasome inhibitor |
tenatoprazole | Tenatoprazole: structure in first source | imidazopyridine | |
tram 34 | TRAM 34: inhibits IKCa1; structure in first source | organochlorine compound | |
1-methyltryptophan | 1-methyltryptophan : A tryptophan derivative that is tryptophan carrying a single methyl substituent at position 1 on the indole. 1-methyltryptophan: an immunomodulator | indolyl carboxylic acid | |
benzyloxycarbonyl-phe-ala-fluormethylketone | cathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1). | ||
am 404 | anilide | ||
lactacystin | lactam; S-substituted L-cysteine | ||
clasto-lactacystin beta-lactone | clasto-lactacystin beta-lactone: active metabolite of lactacystin; inhibits 20 S proteasome; structure in first source | ||
marizomib | marizomib: a proteasome inhibitor from a marine bacterium Salinospora; structure in first source | beta-lactone; gamma-lactam; organic heterobicyclic compound; organochlorine compound; salinosporamide | antineoplastic agent; proteasome inhibitor |
carfilzomib | epoxide; morpholines; tetrapeptide | antineoplastic agent; proteasome inhibitor | |
crizotinib | crizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER. | 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
tyropeptin a | tyropeptin A: proteasome inhibitors produced by Kitasatospora sp. MK993-dF2; structure in first source | dipeptide | |
pr-957 | |||
delanzomib | C-terminal boronic acid peptide; phenylpyridine; secondary alcohol; threonine derivative | antineoplastic agent; apoptosis inducer; proteasome inhibitor | |
belactosin a | belactosin A: isolated from Streptomyces; structure in first source | ||
oprozomib | ONX 0912: antineoplastic; an orally active proteasome inhibitor; structure in first source | ||
ixazomib | ixazomib : A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixazomib citrate, it is used in combination therapy for treatment of multiple myeloma. ixazomib: a proteasome inhibitor with antineoplastic activity; MLN2238 is the biologically active form of MLN9708; structure in first source | benzamides; boronic acids; dichlorobenzene; glycine derivative | antineoplastic agent; apoptosis inducer; drug metabolite; orphan drug; proteasome inhibitor |
as1949490 | |||
galloflavin | galloflavin: structure in first source | ||
cyclic guanosine monophosphate-adenosine monophosphate | 2'-3'-cGAMP : A cyclic purine dinucleotide that consists of AMP and GMP units cyclised via 3',5'- and 2',5'-linkages respectively. | adenyl ribonucleotide; cyclic purine dinucleotide; guanyl ribonucleotide |